The American College of Cardiology (ACC) said it would add Veradigm's technology and analytic capabilities to its Pinnacle Registry and Diabetes Collaborative Registry.
ACC said the partnership would leverage Veradigm's large specialist and primary care provider network on Allscripts and Practice Fusion electronic medical records to bring ACC's clinical guidelines, decision pathways and wealth of provider and patient engagement tools to the point of care.
In November 2018 Allscripts (NASDAQ: MDRX) announced that Veradigm would be the new branding for its Payer & Life Sciences division. Veradigm is led by Tom Langan, former CEO of Practice Fusion, which Allscripts acquired for $100 million in 2018.
By combining Veradigm’s access to a large multi-specialty ambulatory electronic health record network with ACC's NCDR Pinnacle Registry and Diabetes Collaborative Registry, the largest outpatient clinical data registries covering cardiovascular disease and diabetes, the partnership will create the largest ambulatory chronic disease network in the United States with more than 250,000 clinicians and 100 million patients.
"ACC and Veradigm are transforming how cardiovascular and diabetes care are delivered by providing clinicians access to the right clinical information at the right time to improve the outcomes of their patients," said Richard J. Kovacs, M.D., president of the ACC, in a statement. "As information technology transforms how we practice medicine, it is essential that we partner with the most accomplished innovators to ensure our field has full access to the fruit of technology's progress. Our partnership with Veradigm will ensure we continue to meet our commitments to registry participants while preparing to deliver a whole new generation of clinical tools and research opportunities."
The two organizations said patients would have greater opportunities to participate in research studies and have increased access to evidence-based medicine and tools, while providers could expect clinical workflow solutions to be deployed more seamlessly at the point-of-care.
By leveraging registry data, health plans benefit from targeted interventions for disease management and population health initiatives, while life sciences researchers have access to the largest combined cardiovascular database, with over 100 million patients, for a variety of scientific studies. To date, Pinnacle Registry and Diabetes Collaborative Registry research has been used to highlight real-world impacts of new clinical guidelines and identify where gaps in evidence-based care exist.
